Want to join the conversation?
$PRGO said t was sued by Galderma Laboratories, L.P. and Nestle Skin Health S.A. over the company's Paragraph IV ANDA filing for the generic version of Mirvaso (brimonidine) topical gel 0.33% which is indicated for the topical treatment of persistent (nontransient) erythema of rosacea in adults 18 years of age or older.
$JNJ down 2% in pre-market trading. Earnings beat expectations, but sales disappointed. Johnson is cautious on its outlook. How it will perform in the future?
$YHOO is reporting today after market close. Nobody cares about this stock.